Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Papadaki MA"'
Autor:
Sotiris I. Kotsopoulos MD, PhD, FRCPC, Katerina Karaivazoglou MD, PhD (child psychiatrist), Irene S. Florou Msc (psychologist), Maria I. Gyftogianni MA (speech therapist), Ermioni J. Papadaki MA (social worker), Angelique Kotsopoulou PhD (speech pathologist)
Publikováno v:
Global Pediatric Health, Vol 8 (2021)
Objective of the present study was the assessment of the effect of a systematic community intervention offered at an early age to 32 children with autism spectrum disorder (ASD), 2 to 5 year after completion of treatment while attending public school
Externí odkaz:
https://doaj.org/article/aa16483bd078482e8b4dc8b7cc5dc05b
Publikováno v:
E3S Web of Conferences, Vol 585, p 09008 (2024)
Light pollution refers to the result of excessive and incorrectly targeted artificial lighting, which is observed in large cities and is mainly identified by the absence of starry skies. The purpose of this research is the interdisciplinary analysis
Externí odkaz:
https://doaj.org/article/5c89f902fc3445ecb383b63fba99e70e
Autor:
Papadaki Maria, Tzvetkova-Arsova Mira
Publikováno v:
Specijalna Edukacija i Rehabilitacija, Vol 12, Iss 4, Pp 481-499 (2013)
Blindness has been interpreted in different, often controversial ways, since ancient times. It has been stereotyped and labeled by sighted people and has thus affected the acceptance of Visually Impaired persons, the tolerance towards them and their
Externí odkaz:
https://doaj.org/article/fbc8f946ea8e476fa8531e9da1145f20
Autor:
Papadaki Maria E, Lietman Steven A, Levine Michael A, Olsen Bjorn R, Kaban Leonard B, Reichenberger Ernst J
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 7, Iss Suppl 1, p S6 (2012)
Abstract Cherubism is a skeletal dysplasia characterized by bilateral and symmetric fibro-osseous lesions limited to the mandible and maxilla. In most patients, cherubism is due to dominant mutations in the SH3BP2 gene on chromosome 4p16.3. Affected
Externí odkaz:
https://doaj.org/article/f2d5ad134f6e42188e2f5d4c882f692c
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 7, Iss Suppl 1, p S5 (2012)
Abstract Cherubism is a rare bone dysplasia that is characterized by symmetrical bone resorption limited to the jaws. Bone lesions are filled with soft fibrous giant cell-rich tissue that can expand and cause severe facial deformity. The disorder typ
Externí odkaz:
https://doaj.org/article/0db9658b3a7b412d9651f3d75f72b4bd
Autor:
Papadaki MA; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Papadaki E; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Chatziavraam S; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Aggouraki D; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Michaelidou K; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Fotsitzoudis C; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece., Vassilakopoulou M; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece., Mavroudis D; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece., Agelaki S; Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, 70013 Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Aug 23; Vol. 16 (17). Date of Electronic Publication: 2024 Aug 23.
Autor:
Michaelidou K; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece., Karniadakis I; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece., Pantelaion V; Department of Pathology, Evangelismos General Hospital, Athens, Greece., Koutoulaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece., Boukla E; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece., Folinas K; Department of Medical Oncology, Evangelismos General Hospital, Athens, Greece., Dimaras P; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece., Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece., Koutsopoulos AV; Department of Pathology, University General Hospital of Heraklion, Crete, Greece., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece., Vourlakou C; Department of Pathology, Evangelismos General Hospital, Athens, Greece., Mavridis K; Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology-Hellas (FORTH), Heraklion, Crete, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Crete, Greece.
Publikováno v:
Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2024 Jan-Feb; Vol. 24 (1-2), pp. 89-98. Date of Electronic Publication: 2024 Jan 11.
Autor:
Monastirioti A; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Papadaki C; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Kalapanida D; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece., Rounis K; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, 17164 Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden., Michaelidou K; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Vassilika Vouton, 71003 Heraklion, Crete, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Vassilika Vouton, 71110 Heraklion, Crete, Greece.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Sep 28; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 28.
Autor:
Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece., Mala A; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece., Merodoulaki AC; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece., Vassilakopoulou M; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece., Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, 71003 Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71500 Heraklion, Greece.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 12; Vol. 14 (16). Date of Electronic Publication: 2022 Aug 12.
Autor:
Papadaki MA; Laboratory of Translational Oncology, School of Medicine, University of Crete, 70013 Heraklion, Greece., Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, 70013 Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Greece.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Mar 04; Vol. 14 (5). Date of Electronic Publication: 2022 Mar 04.